CRM1 mediates ASC nuclear export and inflammasome activation
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114503 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Rui Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of immune response and immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic M…. Hauptthemen laut MEDLINE: Inflammasomes, Karyopherins, Receptors, Cytoplasmic and Nuclear, CARD Signaling Adaptor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Anhui Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammasomes are multiprotein complexes of the innate immune system that sense different pathogens or danger signals, and have been implicated in the pathogenesis of multiple human inflammatory diseases. The translocation of adaptor protein ASC from the nucleus to the cytosol is important for inflammasome assembly and activation, but the mechanism remains unclear. Here we show that pharmacological inhibition or genetic deletion of chromosome region maintenance 1 (CRM1) in macrophages significantly inhibits the activation of NLRP3, AIM2, NLRC4 and pyrin inflammasomes. Mechanistically, CRM1 directly binds to the PYD domain of ASC to promote its nuclear-cytosolic transport. More importantly, treatment with CRM1 inhibitor KPT-330 or deletion of CRM1 in myeloid cells attenuates the pathological symptoms of experimental autoimmune encephalomyelitis (EAE) in mice. Thus, our findings reveal that CRM1 is an essential mediator for ASC nuclear export to promote inflammasome assembly and activation, which provides a potential target for inflammasome-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of immune response and immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of…
- Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, China.
- Insitute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230601, China. Electronic address: hy527@ihm.ac.cn.
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Anhui Province
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Cao, R., Lin, B., He, H., Wang, D., Wang, X., Huang, Y., & Zhou, R. (2025). CRM1 mediates ASC nuclear export and inflammasome activation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114503
Vancouver
Cao R, Lin B, He H, Wang D, Wang X, Huang Y, et al. CRM1 mediates ASC nuclear export and inflammasome activation. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114503
BibTeX
@article{Cao2025,
author = {Cao, Rui and Lin, Bolong and He, Hongbin and Wang, Di and Wang, Xiaqiong and Huang, Yi and Zhou, Rongbin},
title = {CRM1 mediates ASC nuclear export and inflammasome activation},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114503}
}
EUVIMED